3175 results for «555»

Filter By

3175 results

Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for

18 May 2022 – From EuroPCR 2022

Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO...

Cre8 EVO: the 'sweetest advancement' that a diabetic patient is waiting for

Conquer calcium with intravascular lithotripsy (IVL): cases and clinical data

18 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session mainly focuses on the DISRUPT CAD studies: hear discussion on the latest DISRUPT CAD clinical evidence supporting the use of IVL across different calcium morphologies, appraise the most recent one-year OCT-pooled analysis of the DISRUPT CAD III and IV studies, and learn about the differences...

Conquer calcium with intravascular lithotripsy (IVL): cases and clinical data

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

18 May 2022 – From EuroPCR 2022

What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things

18 May 2022 – From EuroPCR 2022

Based on the didactic analysis of several practical cases, and also on the latest guidelines and study outcomes on the subject, learn in this EuroPCR 2022 session new management strategies to optimise PCI in diffuse coronary artery disease, new developments of the Optowire to support decision-making in patients...

The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things

Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions

18 May 2022 – From EuroPCR 2022

Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...

Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions

From access to closure in transcatheter valve procedures - Optimising patients' outcomes step by step

18 May 2022 – From EUROPCR 2022

Watch this EuroPCR 2022 session to learn the key steps in transcatheter mitral valve repair and transcatheter aortic valve implantation procedures. 
Follow step by step how to optimally access and close venous large bore access sites using suture mediated vessel closure devices, and learn about the key...

From access to closure

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve

18 May 2022 – From EuroPCR 2022

The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent and VitaFlow valve

Pressure microcatheter guided PCI: to optimise stent implantation and to safely assess the functional result

18 May 2022 – From EuroPCR 2022

Through the case study of a 71-year-old female patient with hypertension, dyslipidemia, previous TIA, and stress-induced chest pain, among other things, this EuroPCR 2022 session will allow you to understand the major role of longitudinal functional evaluation of CAD, learn tips and tricks in using pressure microcatheter in PCI...

Pressure microcatheter guided PCI: to optimise stent implantation and to safely assess the functional result

Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES

19 May 2022 – From EuroPCR 2022

Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.

Simplifying complex coronary

State-of-the-art imaging for structural heart disease interventions

19 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to focus on imaging and help understand what imaging has changed in recent years: learn how to perform pre-procedural planning and how advanced imaging can make procedures easier and safer.

State-of-the-art imaging for structural heart disease interventions

Robotic PCI: evolution or R-Evolution

19 May 2022 – From EuroPCR 2022

Consult this session including a recorded case, and learn more about robotic PCI - its benefits and recent clinical results. Discover what might be the future of robotic PCI.

Robotic PCI: evolution

A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)

30 Oct 2024

Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.

Nicola Ryan

Author

Nicola Ryan
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)

GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial

21 Nov 2024

Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
GLORIOUS

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
Didn’t find what you were looking for?